Results 131 to 140 of about 988,945 (329)
Fat Embolism Syndrome in a Preoperative Patient
Dyspnea following a long bone fracture brings in the possibility of fat embolism, especially if the symptoms start around 48–72 h after the trauma.
Sunny George +6 more
doaj +1 more source
Background Autologous fat injection is getting popular in cosmetic procedures, however, still has a risk of fat embolism. Herein, we report the first case of segmental ischaemic infarction of the iris, which occurred after autologous fat injection into ...
Jaeyoung Kim, Sa Kang Kim, Mee Kum Kim
doaj +1 more source
Abstract Heart failure with preserved ejection fraction (HFpEF) is characterized by a lack of a specific targeted treatment and a complex, partially unexplored pathophysiology. Common comorbidities associated with HFpEF are hypertension, atrial fibrillation, obesity and diabetes.
Giorgia D'Italia +2 more
wiley +1 more source
The effects of sodium–glucose cotransporter 2 inhibitors on the ‘forgotten’ right ventricle
Abstract With the progress in diagnosis, treatment and imaging techniques, there is a growing recognition that impaired right ventricular (RV) function profoundly affects the prognosis of patients with heart failure (HF), irrespective of their left ventricular ejection fraction (LVEF).
Liangzhen Qu, Xueting Duan, Han Chen
wiley +1 more source
Quality of Life Following Massive Weight Loss and Body Contouring Surgery: an Exploratory Study. [PDF]
Reconstructive surgery is a major growth intervention for body improvement, enhancing appearance and psychological well-being following massive weight loss.
Gilmartin, J, Long, AF, Soldin M
core
Effectiveness of Decompressive Hemicraniectomy to Treat a Life-Threatening Cerebral Fat Embolism
Background and Importance Cerebral fat embolism (CFE) occurs mainly after long-bone fractures. Often reducing to minor neurological disorders as confusion, it can sometimes cause more severe consequences such as coma or even death.
Charlène Couturier +4 more
semanticscholar +1 more source
Considerations for drug trials in hypertrophic cardiomyopathy
Abstract Hypertrophic cardiomyopathy (HCM) is a heterogeneous condition with potentially serious manifestations. Management has traditionally comprised therapies to palliate symptoms and implantable cardioverter‐defibrillators to prevent sudden cardiac death. The need for disease‐modifying therapies has been recognized for decades.
John P. Farrant +17 more
wiley +1 more source
Vertebro-/Kyphoplasty History, Development, Results [PDF]
Many investigations prove the significant analgetic effect of vertebral augmentation. The reasons for the decrease in pain are found in the stabilization of fracture fragments as well as the toxic-thermic effect of polymethylmethacrylate (PMMA), used in ...
Armsen, Nils, Boszczyk, Bronek
core
After collecting Musa paradisiaca leaves, some were dried and others were used to produce aqueous extracts. The extracts and powders were characterized and then administered to rats made anaemic by PHZ. After 14 days of administration of the two samples, the rats were euthanized and it was observed that after 9 days of treatment, the aqueous extract ...
Josée Rebeca Nombo +8 more
wiley +1 more source
It provides a conceeptual framework of the core components required for w/o PE development and various internal and external factors determining the emulsion stabilization. It also emphasizes the emerging application of w/o PE in diverse industrial use such as encapsulation and delivery, packaging, food, biomedical, etc.
Bibha Mishra A., Vidisha Tomer
wiley +1 more source

